(19)
(11) EP 3 625 329 A1

(12)

(43) Date of publication:
25.03.2020 Bulletin 2020/13

(21) Application number: 18728049.0

(22) Date of filing: 14.05.2018
(51) International Patent Classification (IPC): 
C12N 5/00(2006.01)
C07K 14/535(2006.01)
 C07K 14/755(2006.01)
(86) International application number:
PCT/EP2018/062418
(87) International publication number:
WO 2018/210771 (22.11.2018 Gazette 2018/47)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 17.05.2017 EP 17171577

(71) Applicant: Octapharma AG
8853 Lachen (CH)

(72) Inventors:
  • WINGE, Stefan
    12050 Årsta (SE)
  • SAFTA, Jade
    Branchburg, NJ 08876 (US)
  • AIZAWA, Peter
    12149 Johanneshov (SE)
  • SCHWIENTEK, Tilo
    41468 Neuss (DE)

(74) Representative: Patent- und Rechtsanwälte Ullrich & Naumann 
PartG mbB Schneidmühlstrasse 21
69115 Heidelberg
69115 Heidelberg (DE)

   


(54) METHOD FOR THE PRODUCTION OF A RECOMBINANT TARGET PROTEIN